Artificial pancreas achieves glycaemic control in type 2 diabetes says study

A closed-loop insulin-delivery system in inpatients with type 2 diabetes receiving noncritical care achieves “significantly better” glycaemic control than conventional insulin therapy, a study published in The New England Journal of Medicine has concluded. 

The findings also showed this was achieved without a higher risk of hypoglycaemia. The study, part funded by Diabetes UK, aimed to build on evidence highlighting the benefits of a closed-loop delivery system (artificial pancreas) in type 1 diabetes by exploring its use in people with type 2 diabetes receiving noncritical care.

Leave a Reply

Your email address will not be published. Required fields are marked *